Please be advised that this application will be unavailable due to scheduled maintenance from June 18, 2026 at 5:00 PM ET through June 21, 2026. During this time, users will not be able to access the system. Please plan your work accordingly. We apologize for any inconvenience and appreciate your patience.
This document presents communications between NIH/NCATS and the FDA/CBER/OTAT regarding an INTERACT meeting on an investigational gene therapy for propionic acidemia (AAV9-hPCCA, NCATS-BL0746).